César Aguilar

César Aguilar

Auto-generated profile, based on publicly available information

César Aguilar

Laboratorio de Genómica Industrial, Centro de Biotecnología FEMSA, Escuela de Ingeniería y Ciencias, Tecnológico de Monterrey, Av. Eugenio Garza Sada 2501, Sur, Nuevo León, 64700, Mexico

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2022 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
BTBarbara R Terlouw
Barbara R Terlouw
KBKai Blin
Kai Blin
JNJorge C Navarro-Muñoz
Jorge C Navarro-Muñoz
NANicole Avalon
Nicole Avalon
MCMarc Chevrette
Marc Chevrette
MMMarnix H. Medema
Marnix H. Medema
With an ever-increasing amount of (meta)genomic data being deposited in sequence databases, (meta)genome mining for natural product biosynthetic pathways occupies a critical role in the discovery of novel pharmaceutical drugs, crop protection agents and biomaterials. The genes that encode these pathways are often organised into biosynthetic gene clusters (BGCs). In 2015, we defined the Minimum Information about a Biosynthetic Gene cluster (MIBiG): a standardised data format that describes the minimally required information to uniquely characterise a BGC. We simultaneously constructed an accompanying online database of BGCs, which has since been widely used by the community as a reference dataset for BGCs and was expanded to 2021 entries in 2019 (MIBiG 2.0). Here, we describe MIBiG 3.0, a database update comprising large-scale validation and re-annotation of existing entries and 661 new entries. Particular attention was paid to the annotation of compound structures and biological activities, as well as protein domain selectivities. Together, these new features keep the database up-to-date, and will provide new opportunities for the scientific community to use its freely available data, e.g. for the training of new machine learning models to predict sequence-structure-function relationships for diverse natural products. MIBiG 3.0 is accessible online at https://mibig.secondarymetabolites.org/.

14 May 2024 in Microbial Genomics
Verified
Journal Article
Open access
CACésar Aguilar
César Aguilar
AAAmir Alwali
Amir Alwali
MMMadeline Mair
Madeline Mair
LRLorena Rodriguez-Orduña
Lorena Rodriguez-Orduña
HCHaydeé Contreras-Peruyero
Haydeé Contreras-Peruyero
EPElizabeth Ivy Parkinson
Elizabeth Ivy Parkinson
Natural products from Actinomycetota have served as inspiration for many clinically relevant therapeutics. Despite early triumphs in natural product discovery, the rate of unearthing new compounds has decreased, necessitating inventive approaches. One promising strategy is to explore environments where survival is challenging. These harsh environments are hypothesized to lead to bacteria developing chemical adaptations (e.g. natural products) to enable their survival. This investigation focuses on ore-forming environments, particularly fluoride mines, which typically have extreme pH, salinity and nutrient scarcity. Herein, we have utilized metagenomics, metabolomics and evolutionary genome mining to dissect the biodiversity and metabolism in these harsh environments. This work has unveiled the promising biosynthetic potential of these bacteria and has demonstrated their ability to produce bioactive secondary metabolites. This research constitutes a pioneering endeavour in bioprospection within fluoride mining regions, providing insights into uncharted microbial ecosystems and their previously unexplored natural products.

28 January 2024 in Metabolic Engineering
Verified
Journal Article
Closed access
VGVioleta Guadarrama-Pérez
Violeta Guadarrama-Pérez
CACésar Aguilar
César Aguilar
APAlberto Porras-Sanjuanico
Alberto Porras-Sanjuanico
EMEnrique Merino
Enrique Merino
OROctavio T. Ramírez
Octavio T. Ramírez
LPLaura A. Palomares
Laura A. Palomares

17 November 2025 in Nucleic Acids Research
Verified
Journal Article
Open access
CACésar Aguilar
César Aguilar
FFFernando Fontove-Herrera
Fernando Fontove-Herrera
APAnton Pashkov
Anton Pashkov
DGDavid A García-Estrada
David A García-Estrada
HCHaydeé Contreras-Peruyero
Haydeé Contreras-Peruyero
Nelly Selem MojicaNelly Selem Mojica
Nelly Selem Mojica
The microbiome is crucial to agroecosystems, as it influences plant nutrition, resilience, and overall health. Recent advances in metagenomics have expanded our understanding of plant–microbe interactions, yet curated, high-resolution data capturing the global diversity of crop-associated microbiomes remain scarce. To fill this gap, we developed MicroAgroBiome, a publicly accessible platform that offers standardized taxonomic and functional data, mainly from the rhizosphere microbiomes of agriculturally important crops. The platform integrates 554 metagenomes from 28 crops and soil sample health, advancing microbiome-informed agricultural strategies. It also underscores Latin America’s growing leadership in agricultural microbiome research. MicroAgroBiome is available at https://agrobiom.matmor.unam.mx.

9 January 2024 in Journal of Industrial Microbiology and Biotechnology
Verified
Journal Article
Open access
PDF file
AAAmir Y Alwali
Amir Y Alwali
DSDiane Santos
Diane Santos
CACésar Aguilar
César Aguilar
ABAudrey Birch
Audrey Birch
LRLorena Rodriguez-Orduña
Lorena Rodriguez-Orduña
EPElizabeth I Parkinson
Elizabeth I Parkinson
Narrow-spectrum antibiotics are of great interest given their ability to spare the microbiome and decrease widespread antibiotic resistance compared to broad-spectrum antibiotics. Herein, we screened an in-house library of Actinobacteria strains for selective activity against Acinetobacter baumannii and successfully identified Streptomyces sp. CS-62 as a producer of a natural product with this valuable activity. Analysis of the cultures via high-resolution mass spectrometry and tandem mass spectrometry, followed by comparison with molecules in the Natural Product Atlas and the Global Natural Products Social Molecular Networking platform, suggested a novel natural product. Genome mining analysis initially supported the production of a novel kirromycin derivative. Isolation and structure elucidation via mass spectrometry and Nuclear Magnetic Resonance (NMR) analyses revealed that the active natural product was the known natural product factumycin, exposing omissions and errors in the consulted databases. While public databases are generally very useful for avoiding rediscovery of known molecules, rediscovery remains a problem due to public databases either being incomplete or having errors that result in failed dereplication. Overall, the work describes the ongoing problem of dereplication and the continued need for public database curation.

31 October 2025 in Microbial Genomics
Verified
Journal Article
Open access
LRLorena Rodríguez-Orduña
Lorena Rodríguez-Orduña
CACésar Aguilar
César Aguilar
AHAlan Gerardo Hernandez-Melgar
Alan Gerardo Hernandez-Melgar
HGHéctor F. Arocha Garza
Héctor F. Arocha Garza
KVKarina Verdel-Aranda
Karina Verdel-Aranda
CCCuauhtemoc Licona Cassani
Cuauhtemoc Licona Cassani
A corrigendum of this article has been published; full details can be found at [10.1099/mgen.0.001641] Discovery of novel bioactive natural products from Actinomycetota has decreased, motivating the exploration of rare ecosystems. In this work, we integrated genomics and untargeted metabolomics to profile the biosynthetic capacity of Streptomyces and Nocardia strains isolated from two contrasting, Ramsar-listed Mexican biomes with well-defined ecological features: Cuatro Ciénegas, a semi-arid, oligotrophic karst basin with high microbial endemism, and Calakmul, a tropical rainforest characterized by high biodiversity, seasonal wetlands and limestone-derived alkaline soils. We hypothesized that bacteria isolated from contrasting environments would encode for novel and distinctive subsets of secondary metabolites. Using different metabolo-genomic approaches, a diverse collection of Streptomyces and Nocardia strains was identified, including several potentially novel species. Genome mining revealed a large repertoire of biosynthetic gene clusters (BGCs), many without matches to known metabolites, while molecular networking and dereplication (GNPS, SNAP-MS) exposed extensive chemical diversity within the isolates. Targeted synteny/ortholog analyses (CORASON) linked subsets of metabolites to BGCs, confirming actinomycin and collismycin and identifying komodoquinone-, nocardiopsistin- and rubiginone-like clusters. Notably, bioactivity assays of crude extracts demonstrated effective antifungal effects against Candida albicans SC5314 biofilms and planktonic growth, suggesting their potential therapeutic use. These findings reveal a significant untapped chemical space encoded by Actinomycetota from Ramsar sites, while reinforcing the need for improved tools to connect genomic and metabolomic data for natural product discovery.